Nano-X Imaging Ltd. NNOX
Medical Electronics · IPO 2020 · data as of November 13, 2026
Nano-X Imaging Ltd. (NNOX) is a healthcare company listed in the US with a market value of about $25M. In the twelve months to June 30, 2026 it had revenue of $16M and net income of -$117M, a net margin of -747.2%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -37%.
About Nano-X Imaging
Nano-X Imaging is listed in the US and classified in medical electronics, IPO year 2020. Revenue went from $1M in 2021 to $13M in 2025, growth of about 77.8% a year. It was profitable in 0 of the last 8 years in our data. It spends 148% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $13M | $11M | $10M | $9M | $1M | — | — | — |
| Net income | -$117M | -$75M | -$54M | -$61M | -$113M | -$62M | -$44M | -$23M | -$2M |
| Free cash flow | -$52M | -$45M | -$39M | -$48M | -$51M | -$61M | -$36M | -$6M | -$4M |
| EPS (diluted) | $-1.72 | $-0.95 | $-0.68 | $-0.77 | $-1.44 | $-0.79 | $-0.56 | $-0.29 | $-0.02 |
| Net margin | -747.2% | -576.1% | -474.3% | -613.6% | -1320.2% | -4739.1% | — | — | — |
| ROIC | — | -51.7% | -28.7% | -30.5% | -51.5% | -20.6% | -14.9% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $4.13, 1183% above the current price; targets range from $3.00 to $5.00; the consensus rating is “none”; expected EPS is $-0.60 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Nano-X Imaging pay a dividend?
Not currently.
Is Nano-X Imaging a good stock to buy?
We do not give buy or sell advice. Nano-X Imaging scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.